يعرض 1 - 11 نتائج من 11 نتيجة بحث عن '"Spernat D."', وقت الاستعلام: 0.44s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    Relation: pii: pi-2-1-8-2; Spernat, D., Sofield, D., Moon, D., Louie-Johnsun, M. & Woo, H. (2014). Implications of laparoscopic inguinal hernia repair on open, laparoscopic, and robotic radical prostatectomy. Prostate Int, 2 (1), pp.8-11. https://doi.org/10.12954/PI.13032.; http://hdl.handle.net/11343/305018

  3. 3
    Academic Journal
  4. 4
    Conference

    المساهمون: 66th Annual Scientific Meeting of the Urological Society of Australia and New Zealand (13 Apr 2013 - 16 Apr 2013 : Melbourne, Victoria)

    Relation: BJU International, 2013, vol.111, iss.Suppl. 1, pp.31-32; http://hdl.handle.net/2440/93786; Moretti, K. [0000-0002-6712-6551]

  5. 5
    Electronic Resource
  6. 6
  7. 7
    Electronic Resource

    مصطلحات الفهرس: burning sensation/si [Side Effect], cardiovascular symptom/si [Side Effect], chronotropism, clinical protocol, color ultrasound flowmetry, compartment syndrome, conservative treatment, disease association, drug mechanism, drug use, erectile dysfunction/co [Complication], erectile dysfunction/pc [Prevention], erectile dysfunction/th [Therapy], human, hypercapnia/co [Complication], hypercapnia/di [Diagnosis], hypoxia/co [Complication], hypoxia/di [Diagnosis], inotropism, ischemic priapism/dt [Drug Therapy], penile burning sensation/si [Side Effect], penile fibrosis/co [Complication], penile fibrosis/pc [Prevention], penile necrosis/co [Complication], penis discoloration/si [Side Effect], penis disease/si [Side Effect], penis prosthesis, priapism/di [Diagnosis], priapism/dt [Drug Therapy], priapism/et [Etiology], priapism/su [Surgery], adrenergic receptor stimulating agent/ae [Adverse Drug Reaction], adrenergic receptor stimulating agent/dt [Drug Therapy], adrenergic receptor stimulating agent/ca [Intracavernous Drug Administration], adrenergic receptor stimulating agent/po [Oral Drug Administration], adrenergic receptor stimulating agent/pd [Pharmacology], antiandrogen/dt [Drug Therapy], antiandrogen/pd [Pharmacology], baclofen/dt [Drug Therapy], baclofen/pd [Pharmacology], digoxin/dt [Drug Therapy], digoxin/pd [Pharmacology], estrogen/dt [Drug Therapy], estrogen/pd [Pharmacology], etilefrine/dt [Drug Therapy], etilefrine/po [Oral Drug Administration], etilefrine/pd [Pharmacology], gabapentin/dt [Drug Therapy], gabapentin/pd [Pharmacology], gonadorelin derivative/dt [Drug Therapy], gonadorelin derivative/pd [Pharmacology], hydroxyurea/dt [Drug Therapy], hydroxyurea/pd [Pharmacology], metaraminol/dt [Drug Therapy], metaraminol/po [Oral Drug Administration], methylene blue/ae [Adverse Drug Reaction], methylene blue/dt [Drug Therapy], methylene blue/ca [Intracavernous Drug Administration], methylene blue/pd [Pharmacology], phenylephrine/dt [Drug Therapy], phenylephrine/ca [Intracavernous Drug Administration], phenylephrine/po [Oral Drug Administration], phenylephrine/pd [Pharmacology], placebo, plasminogen activator/dt [Drug Therapy], plasminogen activator/ca [Intracavernous Drug Administration], procyclidine/dt [Drug Therapy], procyclidine/pd [Pharmacology], pseudoephedrine/dt [Drug Therapy], pseudoephedrine/pd [Pharmacology], sildenafil/dt [Drug Therapy], sildenafil/pd [Pharmacology], terbutaline/dt [Drug Therapy], terbutaline/po [Oral Drug Administration], terbutaline/pd [Pharmacology], corporal aspiration, ischemic priapism/di [Diagnosis], ischemic priapism/et [Etiology], ischemic priapism/su [Surgery], ischemic priapism/th [Therapy], non ischemic priapism/di [Diagnosis], non ischemic priapism/et [Etiology], non ischemic priapism/su [Surgery], non ischemic priapism/th [Therapy], stuttering priapism/dt [Drug Therapy], stuttering priapism/et [Etiology], stuttering priapism/su [Surgery], drug response, priapism/th [Therapy], priority journal, shunting, side effect/si [Side Effect], surgical technique, vein occlusion, acidosis/co [Complication], acidosis/di [Diagnosis], algorithm, angiography, article, artificial embolism, aspiration, blood gas analysis, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28216
    Click here for full text options
    LibKey Link

  8. 8
    Electronic Resource
  9. 9
    Electronic Resource

    المؤلفون: Spernat D., Kourambas J.

    مصطلحات الفهرس: kidney colic/dt [Drug Therapy], kidney colic/th [Therapy], low fat diet, mental health, nephrotic syndrome/si [Side Effect], pancytopenia/si [Side Effect], priority journal, prophylaxis, protein restriction, purine metabolism, rash/si [Side Effect], recurrent disease/dt [Drug Therapy], recurrent disease/pc [Prevention], risk reduction, side effect/si [Side Effect], sodium restriction, stone dissolution, stone formation/dt [Drug Therapy], stone formation/pc [Prevention], thrombosis/si [Side Effect], ureter stone/dt [Drug Therapy], urolithiasis/dt [Drug Therapy], urolithiasis/th [Therapy], weight reduction, acetohydroxamic acid/ae [Adverse Drug Reaction], acetohydroxamic acid/dt [Drug Therapy], alfuzosin/cm [Drug Comparison], alfuzosin/dt [Drug Therapy], allopurinol/dt [Drug Therapy], alpha adrenergic receptor blocking agent/cm [Drug Comparison], alpha adrenergic receptor blocking agent/dt [Drug Therapy], bicarbonate/dt [Drug Therapy], bicarbonate/po [Oral Drug Administration], calcium/ec [Endogenous Compound], calcium channel blocking agent/dt [Drug Therapy], cellulose phosphate/ae [Adverse Drug Reaction], cellulose phosphate/dt [Drug Therapy], citrate potassium/ae [Adverse Drug Reaction], citrate potassium/cb [Drug Combination], citrate potassium/dt [Drug Therapy], citrate potassium/po [Oral Drug Administration], citric acid/dt [Drug Therapy], corticosteroid/cm [Drug Comparison], corticosteroid/dt [Drug Therapy], deflazacort/cm [Drug Comparison], deflazacort/dt [Drug Therapy], doxazosin/cm [Drug Comparison], doxazosin/dt [Drug Therapy], nifedipine/ct [Clinical Trial], nifedipine/cm [Drug Comparison], nifedipine/dt [Drug Therapy], nonsteroid antiinflammatory agent/dt [Drug Therapy], oxalic acid/ec [Endogenous Compound], penicillamine/ae [Adverse Drug Reaction], penicillamine/cm [Drug Comparison], penicillamine/dt [Drug Therapy], placebo, potassium dihydrogen phosphate/dt [Drug Therapy], scopolamine butyl bromide, tamsulosin/ct [Clinical Trial], tamsulosin/cm [Drug Comparison], tamsulosin/dt [Drug Therapy], terazosin/cm [Drug Comparison], terazosin/dt [Drug Therapy], thiazide diuretic agent/cb [Drug Combination], thiazide diuretic agent/dt [Drug Therapy], tiopronin/ae [Adverse Drug Reaction], tiopronin/cm [Drug Comparison], trometamol/dt [Drug Therapy], uric acid/ec [Endogenous Compound], tiopronin/dt [Drug Therapy], bone pain/si [Side Effect], acid secretion, article, asthenia/si [Side Effect], calcium intake, calcium oxalate stone/dt [Drug Therapy], calcium urine level, cystinuria/dt [Drug Therapy], dermatitis/si [Side Effect], fluid intake, gastrointestinal symptom/si [Side Effect], human, hypercalciuria/dt [Drug Therapy], hypocoagulability/si [Side Effect], Article

  10. 10
    Electronic Resource
  11. 11
    Academic Journal